<?xml version="1.0" encoding="UTF-8"?>
<p>It is also worth noting that the dynamic and complicated nature of many emerging infections often leaves distinctions between emerging and reemerging infections open to question, leading various experts to classify them differently. For example, we describe as “reemerging” new or more severe diseases associated with acquisition of new genes by an existing microbe, e.g., antibiotic resistance genes, even when mutations cause entirely new diseases with unique clinical epidemiologic features, e.g., Brazilian purpuric fever 
 <xref rid="ppat.1003467-Papazisi1" ref-type="bibr">[12]</xref>. Similarly, we refer to SARS as an emerging disease a decade after it disappeared, and apply the same term to the related MERS (Middle East Respiratory Syndrome) β coronavirus which appeared in Saudi Arabia in late 2012 
 <xref rid="ppat.1003467-vanBoheemen1" ref-type="bibr">[13]</xref>.
</p>
